← Back to Treatments
🏅 FDA Orphan Designation

Apokyn

Apomorphine HCl

Manufacturer: MDD US Operations, LLC

Indicated for:
Acute intermittent porphyriaOrphanPeroxisomal disease with epilepsy

FDA-Approved Indications (2)

For the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose-wearing-off" and unpredictable :on/off" episodes) associated with advanced Parkinson's disease

For the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose-wearing-off" and unpredictable "on/off" episodes) associated with advanced Parkinson's disease

Population: adults

Indications & Usage

For the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose-wearing-off" and unpredictable :on/off" episodes) associated with advanced Parkinson's disease

💙 Support Programs

View all →
Apokyn
MDD US Operations, LLC
Apokyn
MDD US Operations, LLC

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.